HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 1,910: Line 1,910:
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| ||
|IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| ||
|Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG
|Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG
| ||
| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Immunoglobulin-related (AL) amyloidosis||Disease|| || || || || ||SG
|Immunoglobulin-related (AL) amyloidosis||Disease|| || || || || ||SG
| ||
| ||
|
|Primary Amyloidosis
|Heather E. Williams, PhD, MS, PgD, ErCLG
|Heather E. Williams, PhD, MS, PgD, ErCLG
|
|?PENDING<br />
|
|
|
|
Line 1,948: Line 1,948:
|Monoclonal immunoglobulin deposition disease||Disease|| || || || || ||SG
|Monoclonal immunoglobulin deposition disease||Disease|| || || || || ||SG
| ||
| ||
|
|Light Chain and Heavy Chain Deposition Disease
|Chen Yang, MD, PhD, University of Michigan
|Chen Yang, MD, PhD, University of Michigan
|
|Complete
|
|10/15/2022
|
|
|-
|-
|Mu heavy chain disease||Disease|| || || || || ||SG
|Mu heavy chain disease||Disease|| || || || || ||SG
| ||
| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Gamma heavy chain disease||Disease|| || || || || ||SG
|Gamma heavy chain disease||Disease|| || || || || ||SG
| ||
| ||
|
|Gamma Heavy Chain Disease
|Manisha Brahmbhatt-Sutariya  Asst. Professor, Dept. of Pathology and Human Anatomy  Technical Supervisor, Clinical Genetics Laboratory  Loma Linda University, Medical Center, CA
|Manisha Brahmbhatt-Sutariya  Asst. Professor, Dept. of Pathology and Human Anatomy  Technical Supervisor, Clinical Genetics Laboratory  Loma Linda University, Medical Center, CA
|
|Complete
|
|5/26/2021
|
|
|-
|-
|Alpha heavy chain disease||Disease|| || || || || ||SG
|Alpha heavy chain disease||Disease|| || || || || ||SG
| ||
| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Plasmacytoma||Disease|| || || || || ||SG
|Plasmacytoma||Disease|| || || || ||author needs to include Solitary plasmacytoma of bone, Extraosseous plasmacytoma (extramedullary) (v4 page did not have content on ccga)
|SG
| ||
| ||
|
|NEW (No Prior) - no content on version 4 page "Plasmacytoma' originally assigned to Zhenya Tang
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Plasma cell myeloma / multiple myeloma||Disease|| || || || || ||SG
|Plasma cell myeloma / multiple myeloma||Disease|| || || || ||Note: author needs to include Plasma_Cell_Myeloma_Variants content in this page||SG
| ||
| ||
|
|(1) Plasma Cell Myeloma + (2) Plasma Cell Myeloma Variants
|*Huan Mo, MD, MS *Zhenya Tang, MD, PhD  The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas
|(1) Huan Mo, MD, MS and Zhenya Tang, MD, PhD  The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas + (2) Fariborz Rashid-Kolvear, PhD, FACMG, FCCMG
|
|Pending
|
|
|
|